ArticleCell death & disease2025

PLK1 or WEE1 inhibition targets homologous recombination repair proficiency in BRCA1/2 wild-type high-grade serous ovarian cancer.

Qian Xi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.